EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities

Giovanni Marasco, Keren Hod iD, Luigi Colecchia iD, Cesare Cremon iD, Maria Raffaella Barbaro, Giulia Cacciari, Francesca Falangone, Anna Kagramanova, Dmitry Bordin, Vasile Drug, Egidia Miftode, Pietro Fusaroli und 48 weitere

United European Gastroenterology Journal · 2025-06 · 13 (5) · 798-818

DOI: 10.1002/ueg2.70005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 21.03.2025. Verfasst von Giovanni Marasco und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: COVID-19, Irritable Bowel Syndrome, Gastrointestinal Diseases, Brain-Gut Axis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Italian Ministry of Health, Fondazione del Monte di Bologna e Ravenna and European Grant, The Italian Ministry of Education, University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has highlighted the potential exacerbation of gastrointestinal symptoms in patients with disorders of gut‐brain interaction (DGBIs). However, the distinct symptom trajectories and psychological burden in patients with post‐COVID‐19 DGBIs compared with patients with pre‐existing irritable bowel syndrome (IBS)/functional dyspepsia (FD) and non‐DGBI controls remain poorly understood.

Objectives

To examine the long‐term gastrointestinal symptom progression and psychological comorbidities in patients with post‐COVID‐19 DGBI, patients with pre‐existing IBS/FD and non‐DGBI controls.

Methods

This post hoc analysis of a prospective multicenter cohort study reviewed patient charts for demographic data and medical history. Participants completed the Gastrointestinal Symptom Rating Scale at four time points: baseline, 1, 6, and 12 months, and the Hospital Anxiety and Depression Scale at 6 and 12 months. The cohort was divided into three groups: (1) post‐COVID‐19 DGBIs (2) non‐DGBI, and (3) pre‐existing IBS/FD, with the post‐COVID‐19 DGBIs group compared to the latter two control groups.

Results

Among 599 eligible patients, 27 (4.5%) were identified as post‐COVID‐19 DGBI. This group experienced worsening abdominal pain, hunger pain, heartburn, and acid regurgitation, unlike symptom improvement or stability in non‐DGBI controls ( p < 0.001 for all symptoms, except hunger pain, p = 0.001). While patients with pre‐existing IBS/FD improved in most gastrointestinal symptoms but worsened in constipation and incomplete evacuation, patients with post‐COVID‐19 DGBI exhibited consistent symptom deterioration across multiple gastrointestinal domains. Anxiety and depression remained unchanged in patients with post‐COVID‐19 DGBI, contrasting with significant reductions in controls (non‐DGBI: p = 0.003 and p = 0.057; pre‐existing IBS/FD: p = 0.019 and p = 0.007, respectively).

Conclusions

COVID‐19 infection is associated with the development of newly diagnosed DGBIs and distinct symptom trajectories when compared with patients with pre‐existing IBS/FD. Patients with post‐COVID‐19 DGBI experience progressive gastrointestinal symptom deterioration and persistent psychological distress, underscoring the need for tailored management strategies for this unique subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Irritable Bowel SyndromeGastrointestinal DiseasesBrain-Gut AxisHumansFemaleMaleMiddle AgedAdultComorbidityProspective StudiesSARS-CoV-2IncidenceDyspepsiaDepressionAnxietyDisease ProgressionSymptom Burden

Stichwörter der Autor:innen

COVID‐19anxietydepressiondisorders of gut‐brain interactionfunctional dyspepsiagastrointestinal symptomsirritable bowel syndromepost‐infection gastrointestinal disorders

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Nutrition Sciences, School of Health Sciences, Ariel University, Ariel, Israel.
  • Assuta Medical Centers, Tel Aviv, Israel.
  • Medical-Surgical Department of Clinical Sciences and Translational Medicine, University Sapienza, Rome, Italy.
  • A. S. Loginov Moscow Clinical Scientific Center, Moscow, Russia.

ORCID-Profile: Keren Hod, Luigi Colecchia, Cesare Cremon, Salem Youssef Mohamed, Elif Sitre Koc, Navkiran Tornkvist, Uday C Ghoshal, Giovanni Maconi, Silvio Danese, Antonio Di Sabatino

Förderung

  • The Italian Ministry of Health
  • Fondazione del Monte di Bologna e Ravenna and European Grant
  • The Italian Ministry of Education, University and Research
  • Fondazione Cassa di Risparmio in Bologna

Zitieren

APA

Marasco, G., Hod, K., Colecchia, L., Cremon, C., Barbaro, M. R., Cacciari, G., Falangone, F., Kagramanova, A., Bordin, D., Drug, V., Miftode, E., Fusaroli, P., Mohamed, S. Y., Ricci, C., Bellini, M., Rahman, M. M., Melcarne, L., Santos, J., Lobo, B., …, & Lee, Y. Y. (2025). Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities. United European Gastroenterology Journal, 13(5), 798-818. https://doi.org/10.1002/ueg2.70005

Vancouver

Marasco G, Hod K, Colecchia L, Cremon C, Barbaro MR, Cacciari G, et al. Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities. United European Gastroenterology Journal. 2025;13(5):798-818. doi:10.1002/ueg2.70005

BibTeX
@article{Marasco2025,
  author = {Marasco, Giovanni and Hod, Keren and Colecchia, Luigi and Cremon, Cesare and Barbaro, Maria Raffaella and Cacciari, Giulia and Falangone, Francesca and Kagramanova, Anna and Bordin, Dmitry and Drug, Vasile and Miftode, Egidia and Fusaroli, Pietro and Mohamed, Salem Youssef and Ricci, Chiara and Bellini, Massimo and Rahman, M Masudur and Melcarne, Luigi and Santos, Javier and Lobo, Beatriz and Bor, Serhat and Yapali, Suna and Akyol, Deniz and Sapmaz, Ferdane Pirincci and Urun, Yonca Yilmaz and Eskazan, Tugce and Celebi, Altay and Kacmaz, Huseyin and Ebik, Berat and Binicier, Hatice Cilem and Bugdayci, Mehmet Sait and Yağcı, Munkhtsetseg Banzragch and Pullukcu, Husnu and Kaya, Berrin Yalınbas and Tureyen, Ali and Hatemi, İbrahim and Koc, Elif Sitre and Sirin, Goktug and Calıskan, Ali Riza and Bengi, Goksel and Alıs, Esra Ergun and Lukic, Snezana and Trajkovska, Meri and Dumitrascu, Dan and Pietrangelo, Antonello and Corradini, Elena and Simren, Magnus and Sjolund, Jessica and Tornkvist, Navkiran and Ghoshal, Uday C and Kolokolnikova, Olga and Colecchia, Antonio and Serra, Jordi and Maconi, Giovanni and De Giorgio, Roberto and Danese, Silvio and Portincasa, Piero and Di Sabatino, Antonio and Maggio, Marcello and Philippou, Elena and Lee, Yeong Yeh},
  title = {Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {5},
  pages = {798--818},
  doi = {10.1002/ueg2.70005}
}
Kostenlos starten →